FIELD: medicine, infectious diseases. SUBSTANCE: method involves every day intramuscular administration of 2-ethyl-3-hydroxy-pyridine hydrochloride (emoxypine) in the dose 1.0 ml for 10 days with antidiphtheric serum simultaneously. Invention can be used for treatment of patients with common and toxic forms of diphtheria. Method ensures to decrease toxic damage of cardiovascular and nervous systems, adrenals and kidneys. EFFECT: enhanced effectiveness of treatment. 10 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING INDICATIONS FOR ADMINISTERING EMOXIPIN IN TREATMENT OF TOXIC DIPHTHERIA | 1998 |
|
RU2137128C1 |
METHOD FOR DETERMINING TOXIC DIPHTHERIA DEVELOPMENT COURSE | 1997 |
|
RU2135998C1 |
METHOD TO TREAT DIPHTHERIA | 1994 |
|
RU2106144C1 |
METHOD OF TREATMENT OF PATIENTS WITH DIPHTHERIA TOXIC FORMS | 1996 |
|
RU2137497C1 |
METHOD OF TREATMENT OF DIPHTHERIA TOXIC FORM IN CHILDREN | 1994 |
|
RU2093179C1 |
METHOD FOR TREATING TOXIC FORMS OF DIPHTHERIA | 1995 |
|
RU2132709C1 |
METHOD FOR PREDICTING THE SEVERITY OF DIPHTHERIA | 2017 |
|
RU2655190C1 |
METHOD OF EARLY PROGNOSIS OF DIPHTHERIA SEVERITY COURSE IN ADULT | 1993 |
|
RU2079139C1 |
METHOD OF TREATMENT OF SICK CHILDREN WITH DIPHTHERIA | 1996 |
|
RU2145871C1 |
METHOD FOR TREATING THE CASES OF ACUTE INFECTIOUS DISEASES OF PERIPHERAL NERVE SYSTEM | 1997 |
|
RU2155612C2 |
Authors
Dates
2000-08-10—Published
1997-10-15—Filed